PRO MEDICUS LIMITED — Director's Dealing 2024

Sep 12, 2024

Listing Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	Pro Medicus Limited
ABN	25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	21 November 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by Anthony Hall
Date of change	13 September 2024
No. of securities held prior to change	25,179,000 ordinary shares consisting off:-24,200,000ordinarysharesheldunder Anthony Barry HALL867,500 ordinary shares held underAkay Superannuation Fund41,500 ordinary shares held underResearch Corporation Pty Ltd astrustee for the Anthony Hall FamilyTrust70,000ordinarysharesheldbyAnthony Hall & David Hall ATFEstate of the Late Ronda Hall

+ See chapter 19 for defined terms.

Appendix 3Y

Class	Ordinary shares
Number acquired	Nil
Number disposed	35,000 ordinary shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	Off market transfer (non-cash)Estimated value $164.39 per share
No. of securities held after change	25,144,000 ordinary shares consisting off:-24,200,000ordinarysharesheldunder Anthony Barry HALL867,500 ordinary shares held underAkay Superannuation Fund41,500 ordinary shares held underResearch Corporation Pty Ltd astrustee for the Anthony Hall FamilyTrust35,000ordinarysharesheldbyAnthony Hall ATF Anthony HallTestamentary Trust.
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	off market transfer

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A

+ See chapter 19 for defined terms.

Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 – +Closed period

Were the interests in the securities or contracts detailed	No
above traded during a +closed period where prior writtenclearance was required?
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

Danny English Company Secretary 13 September 2024

+ See chapter 19 for defined terms.